Filtered By:
Vaccination: Shingles (Herpes Zoster) Vaccine

This page shows you your search results in order of date. This is page number 6.

Order by Relevance | Date

Total 272 results found since Jan 2013.

Inactivated COVID-19 vaccine-related herpes zoster and post-herpetic neuralgia: Three case reports
In this report, we describe three cases of HZ, one of them with post-herpetic neuralgia (PHN) after receiving inactivated COVID-19 vaccine. The first two patients developed HZ 8 and 10 days after vaccination, respectively. When pain could not be controlled with paracetamol and non-steroidal anti-inflammatories, the patients received weak opioid codeine. In addition, the first patient received gabapentin, and the second patient was applied erector spinae plane block. The third patient was admitted 4 months after the diagnosis of HZ and considered to have PHN and pain palliation was provided with tramadol. Although the exact...
Source: Agri Dergisi - April 13, 2023 Category: Anesthesiology Authors: Meltem Kanar Source Type: research

New STELARA ® (ustekinumab) Long-Term Data Support its Established Safety Profile in Inflammatory Bowel Disease and Durable Efficacy in Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, March 4, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced final pooled long-term safety results for STELARA® (ustekinumab) through five years in adults with moderately to severely active Crohn’s disease (CD) and four years in adults with moderately to severely active ulcerative colitis (UC), as well as final four-year clinical and endoscopic outcomes from the UNIFI long-term extension (LTE) study evaluating the efficacy of STELARA for the treatment of adults with moderately to severely active UC.1,2 These data are a part of Janssen’s 22 oral and poster ...
Source: Johnson and Johnson - March 4, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news

Herpes zoster after COVID-19 vaccination, aspect of pain medicine: a retrospective, single-center study
CONCLUSIONS: COVID-19 vaccination-related HZ showed clinical features similar to those ofthe other HZ.PMID:36746903 | DOI:10.17085/apm.22207
Source: Herpes - February 6, 2023 Category: Infectious Diseases Authors: Ji Hye Lee Yu Yil Kim Hyun Joo Heo Ji Hun Park Hyung Gu Cho Geonbo Kim Source Type: research

Herpes Zoster Following COVID-19 Vaccine Booster
CONCLUSIONS COVID-19 vaccination remains an important measure to prevent transmission of infection and to reduce the mortality and morbidity caused by it. However, healthcare practitioners should be aware of the possible association between COVID-19 vaccination and herpes zoster. Appropriate explanation and safety advice on the possible adverse events following COVID-19 vaccination, including herpes zoster infection, should be given to patients. This will facilitate early recognition and treatment of this condition.PMID:36650730 | DOI:10.12659/AJCR.938667
Source: Herpes - January 18, 2023 Category: Infectious Diseases Authors: Muhammad Shah Shahrudin Mohamed-Syarif Mohamed-Yassin Nik Munirah Nik Mohd Nasir Source Type: research

Prevention of Herpes Zoster: A Focus on the Effectiveness and Safety of Herpes Zoster Vaccines
Viruses. 2022 Nov 29;14(12):2667. doi: 10.3390/v14122667.ABSTRACTInfection with varicella zoster virus typically occurs in children and it can cause primary varicella infection or "chickenpox", or it can reactivate later in life and cause herpes zoster or "shingles". Herpes zoster mainly occurs in older adults, causing a reduction in activities of daily living, impacting quality of life, and may lead to serious complications, including chronic pain. Two vaccines are marketed to prevent herpes zoster: the live zoster vaccine and the non-live, recombinant zoster vaccine. The pre-licensure clinical trials show the efficacy of...
Source: Herpes - December 23, 2022 Category: Infectious Diseases Authors: Yasmin Marra Fawziah Lalji Source Type: research

Zoster sine herpete
A previous patient came in with a new problem of severe right neck pain that wrapped around to the shoulder, about in a C4 distribution. Nothing on her C spine MRI to explain it, and her skin was hypersensitive to touch. Denied history of rash in the area but did have shingles several years ago on her face. Topicals weren’t helping and she got side effects with oral antineuropathics. She hadn’t had her shingles vaccine, so I told her to go ahead and get it, and that maybe it would help... Read more
Source: Student Doctor Network - December 5, 2022 Category: Universities & Medical Training Authors: callmeanesthesia Tags: Pain Medicine Source Type: forums

EE396 Public Health Impact and Cost-Effectiveness of Herpes Zoster Vaccination for Older Adults in the Netherlands
Varicella-zoster virus (VZV) causes chickenpox in children, and subsequently establishes a latent infection in dorsal root ganglia in the spinal cord. Decades later, it may reactivate, causing herpes zoster (HZ), a painful dermatomal skin rash ( “shingles”), in adults and especially in older individuals. Reactivation of latent VZV is mostly due to immunosenescence, i.e., an age-related functional decline of the immune system. A potential complication linked to HZ is postherpetic neuralgia (PHN), characterised by neuropathic pain which c an last for months or years.
Source: Value in Health - December 1, 2022 Category: International Medicine & Public Health Authors: S Van der Pol, N Giannelos, S Joost, JC Wilschut, MJ Postma, C Boersma Source Type: research

EE265 Health, Productivity and Budget Impact of Vaccinating 50-64 Year Old Employees in Austria Against Herpes Zoster With Recombinant Zoster Vaccine
Herpes zoster (HZ) is caused by reactivation of latent varicella zoster virus. Age-related immunity decline is the main risk factor for the disease. HZ can lead to debilitating chronic pain (postherpetic neuralgia, PHN) and other complications, impacting work productivity. We assessed the public health and budget impact of vaccination with recombinant zoster vaccine (RZV) to Austrian healthcare payers and to employers, respectively.
Source: Value in Health - December 1, 2022 Category: International Medicine & Public Health Authors: ML Nishimwe, G Uhl Source Type: research

Viruses, Vol. 14, Pages 2667: Prevention of Herpes Zoster: A Focus on the Effectiveness and Safety of Herpes Zoster Vaccines
lji Infection with varicella zoster virus typically occurs in children and it can cause primary varicella infection or “chickenpox”, or it can reactivate later in life and cause herpes zoster or “shingles”. Herpes zoster mainly occurs in older adults, causing a reduction in activities of daily living, impacting quality of life, and may lead to serious complications, including chronic pain. Two vaccines are marketed to prevent herpes zoster: the live zoster vaccine and the non-live, recombinant zoster vaccine. The pre-licensure clinical trials show the efficacy of ...
Source: Viruses - November 29, 2022 Category: Virology Authors: Yasmin Marra Fawziah Lalji Tags: Review Source Type: research

Natural History of Herpes Zoster in the Placebo Groups of Three Randomized Phase  III Clinical Trials
ConclusionThe incidence and burden of HZ is high in immunocompetent adults aged ≥ 50 YOA and even more so in HSCT recipients aged ≥ 18 YOA.Graphical Abstract
Source: Infectious Diseases and Therapy - November 23, 2022 Category: Infectious Diseases Source Type: research